TTUHSC Amarillo Campus
HomeAmarillo CampusNews & Events

1999-2004 Publications

TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER
SCHOOL OF MEDICINE at AMARILLO

  1. Ivanov O, Abowd M, Thompson J, Chaudhuri B, Chaudhuri P, ARREDONDO M. Low hormone receptor expression in breast cancer patients with diabetes mellitus. (Manuscript submitted, 1999)

  2. Ivanov O, Thompson J, Chaudhuri B, Chaudhuri P, ARREDONDO M. Relationship between insulin-like receptor 1 and hormone receptor expression in human breast tumors. (Manuscript in review, 1999)

  3. ARREDONDO M, Bollin B, Manley M, Chaudhuri P. Isolated limb perfusion with doxorubin in lieu of adjuvant radiation treatment for resected high grade extremity sarcoma. (Manuscript in review, 1999)

  4. Markusen TE, BARCLAY DL. Current Obstetrics and Gynecologic Diagnosis and Treatment , DeCherney AH, Nathan L (ed), Ed 9, 2003, Chap. 34, Lange Medical Books and McGraw Hill, Benign disorders of the vulva & vagina, p.651-676.

  5. Satmary WS, Memarzadeh S, Smith DM, BARCLAY DL. Current Obstetrics & Gynecologic Diagnosis and Treatment , DeCherney AH, Nathan L (ed), Ed 9, 2003, Chap. 46, Lange Medical Books and McGraw Hill, Premalignant & malignant disorders of the vulva & vagina, p.879-893.

  6. BARCLAY DL. Developed video tape and CD on Supralevator vaginectomy: Operative technique.

  7. Curry SL, BARCLAY DL. Current Obstetric & Gynecologic Diagnosis & Treatment , DeCherney AH, Pernoll ML (ed) (Ed 9) 2003, Appleton & Lange, Benign disorders of the vulva & vagina.

  8. Smith DM, BARCLAY DL, DeCherney AH, Pernoll ML (Ed 9) 2003, Appleton & Lange, Premalignant & malignant disorders of the vulva & vagina.

  9. Siddiqui AA, Guiterrez C, BERK SL.Diagnosis of strongyloides stercoralis by kinyoun acid fast staining, J of Helminthology 73:187-188, 1999.

  10. Smith JK, Siddiqui AA, Krishnaswamy GA, Dykes R, BERK SL, Magee M, Joyner W, Cummins J. Oral interferon-alpha stimulates ISG-15 transcription and production by human buccal epithelial cells, J Interferon Cytokine Res 8:923-28, 1999.

  11. Smith JK, Siddiqui AA, Modica L, Dykes R, Simmons C, Schmidt J, Krishnaswamy G, BERK SL. Interferon alpha upregulates gene expression of aquaporin-5 in human parotid gland, J Interferon Cytokine Res 8:929-935, 1999.

  12. Smith JK, Dykes R, Douglas J, Krishnaswamy G, BERK SL. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease, Journal of the American Medical Association 281:1722-1727, 1999.

  13. Gantz NM, Brown RB, BERK SL, Maki D, Esposito A. Manual of Clinical Problems in Infectious Disease , Lippincott, Williams & Wilkins, 4 th Edition, Philadelphia, PA, 1999.

  14. Robinson J, Ahmed Z, Siddiqui AA, Roy T, BERK SL, Smith JK, Krishnaswamy G. A patient with persistent wheezing, sinusitis, elevated IgE and eosinophilia, Ann Allergy Asthma Immunol 82:144-149, 1999.

  15. Siddiqui AA, Stanley CS, Skelly PJ, BERK SL. A cDNA encoding a nuclear hormone receptor of the steroid/thyroid hormone receptor superfamily from the human parasitic nematode strongyloides stercoralis, Parasitol Res 86:24-29, 2000.

  16. Walker ES, Neal CS, Laffan E, Kalbfleisch JH, BERK SL. Long-term trends in susceptibility of moraxella catarrhalis: A population analysis, J Antimicrob Chemother 45:175-182, 2000.

  17. Siddiqui AA, Stanley CS, BERK SL. A cDNA encoding the highly immunodominant antigen of stongyloides stercoralis: Gamma subunit of isocitrate dehydrogenase (NAD + ), Parasitology Res 86:279-283, 2000.

  18. BERK SL, Davis WR. Medicine PreTest: Self-Assessment and Review , McGraw Hill Publishers, 9 th Edition, New York, 2000.

  19. Siddiqui AA, BERK SL. Diagnosis of strongyloidiasis, Parasitology Today . (In press)

  20. Olive K, BERK SL. Genitourinary tract infection in the elderly, Geriatric Care , J. E. Morley, Ed., Mosby & Co. (In press)

  21. BERK SL, Williams E. Central nervous system infections, Geriatric Care , J. E. Morley, Ed., Mosby & Co. (In press)

  22. BERK SL. Infectious disease, Geriatric Review Syllabus , 4 th Edition, American Geriatric Society, 2000.

  23. Myers JW, BERK SL. Other causes of bacterial pneumonia, Respiratory Infections, 2 nd Edition, Chapter 29: 391-403, Lippincott, Williams & Wilkins, 2000.

  24. BERK SL, Myers JW. Group B streptococcus and other non-pneumococcal streptococcus, Community-Acquired Pneumonia . (In press)

  25. BERK SL, Myers JW. Prosthetic device infections, infectious disease in the aging, A Clinical Handbook, Chapter 17: 197-210, Humana Press, 2000.

  26. Naqvi M, BISKINIS EK, Khattak A. Effect of 50% sucrose on pain response in full term male infants during circumcision. Poster presentation, Pediatric Academic Societies 1999 Annual Meeting, San Francisco, CA, May 1-4, 1999.

  27. Mathis K, Hasham-ulhaq M, Gallou D, BISKINIS EK, Rohrer J, Naqvi M: Is bottle-feeding by a surrogate mother as effective in controlling pain as breastfeeding is in the term neonate? Accepted for platform presentation, Pediatric Academic Societies 2003 Annual meeting, Seattle, WA, May 3-6, 2003.

  28. Kraemer RR, Johnson LG, Haltom R, Kraemer GR, Hebert EP, Gimpel TL, CASTRACANE VD. Serum leptin concentrations in response to acute exercise in postmenopausal women with and without hormone replacement therapy, Proc Soc Exp Biol Med 221:171-177, 1999.

  29. Henson MC, CASTRACANE VD, O=Neil JS, Gimpel TL, Swan KF, Green AE, Shi W. Serum leptin concentrations and expression of leptin transcripts in placental trophoblast with advancing baboon pregnancy, J Clin Endocrinol Metab 84:2543-2549, 1999.

  30. Kraemer RR, Kraemer GR, Acevedo EO, Hebert EP, Temple E, Bates M, Etie A, Haltom R, Quinn S, CASTRACANE VD. Effects of aerobic exercise on serum leptin levels in obese women, Eur J of Appl Physiol 80:154-158, 1999.

  31. Goldzieher JW, Zerwekh JE, CASTRACANE VD. Single-monthly-dose vitamin D supplementation in the elderly, Endocrine Practice 5:229-232, 1999.

  32. Concannon PW, CASTRACANE VD, Rawson RE, Tennant BC. Circannual changes in free thyroxine, prolactin, testes and relative food intake in woodchucks (Marmota monax), American Journal Physiology 277 (Regulatory Integrative Comp Physiol 46):R1401-R1409, 1999.

  33. CASTRACANE VD. Pregnant with anticipation: Endocrinology of pregnancy, Ed. Fuller W, Bazer, Totowa, Humana, 1998, Trends in Endocrinol and Metab 10 (4):168, 1999.

  34. Vas V, Tawwater B, Gimpel TL, CASTRACANE VD. Longitudinal study of bone degradation markers throughout pregnancy, Journal of the Society for Gynecologic Investigation 6 (Program Suppl.):186A (Abst. 548), 1999.

  35. Palmgren MS, Longo SA, Lapeyer E, Andrews S, CASTRACANE VD. Serial maternal leptin concentrations in pregnant diabetic women, Journal of the Society for Gynecologic Investigation 6 (Program Suppl.):187A (Abst. 551), 1999.

  36. CASTRACANE VD, Siler-Khodr TM, Fazleabas AT, Henson MC, Gimpel TL. Serum leptin changes in the early postimplantation period in the pregnant baboon. Presented at the 81 th Annual Meeting of the Endocrine Society, San Diego, CA, Program and Abstracts, p.137 (Abst. No. P1-12), 1999.

  37. CASTRACANE VD, Gimpel TL, Tawwater BA, Kraemer RR, Khosravi MJ, Diamandi A, Krishna R, Bodani U, Bandala M, Mistry J. Characteristics of a family of human leptin immunoassays. Presented at the 81 th Annual Meeting of the Endocrine Society, San Diego, CA, Program and Abstracts, p.225 (Abst. No. P1-430), 1999.

  38. Akinbami MA, CASTRACANE VD, Gould KG, Mann DR. A longitudinal study of leptin during development in the male rhesus monkey. Presented at the 81 th Annual Meeting of the Endocrine Society, San Diego, CA, Program and Abstracts, p.300 (Abst. No. P2-90), 1999.

  39. Kraemer RR, Acevedo EO, Synovitz L, Hebert EP, Caronne M, CASTRACANE VD. Leptin and steroid hormone responses to exercise in adolescent female runners over a 7 week season, Medicine and Science in Sports and Exercise 31:S269 (Abst. No. 1314), 1999.

  40. Mistry J, Tran T, Bodani U, Khosravi MJ, Diamandi A, Tawwater B, CASTRACANE VD. A new enzyme-linked immunosorbant assay for free b hCG, Clinical Chemistry 45(S6):A79 (Abst. No. 269), 1999.

  41. CASTRACANE VD, Childress E, Tawwater B, Vankrieken L, El Shami AS. Androgen parameers in hirsute and normal female patients: Is there a role for the free androgen index (FAI)? Clinical Chemistry 45 (S6):A80 (Abst. No.272), 1999.

  42. CASTRACANE VD, Gimpel TL, Pregger K, El Shami AS. Establishment of thyroid hormone normative data in pregnant women, Clinical Chemistry 45 (S6):A81 (Abst. No. 277), 1999.

  43. CASTRACANE VD, Gimpel TL, Vankrieken L, El Shami AS. Serum thyroxine binding globulin (TBG) and sex hormone binding globulin (SHBG): Reference ranges established throughout pregnancy using the IMMULITE7 chemiluminescent system, Clinical Chemistry 45(S6):A81 (Abst. No. 274), 1999.

  44. CASTRACANE VD, Gimpel TL, Vankrieken L, Durham AP, El Shami AS. Circulating human chorionic gonadotropin (hCG) throughout pregnancy as determined by the IMMULITE: Comparison of combined cross-sectional statistics with individual trajectories, Clinical Chemistry 45 (S6):A81 (Abst. No. 276), 1999.

  45. Vankrieken L, Van der Horst FAL, CASTRACANE VD, Durham AP, El Shami AS. An international multicenter reference range study of normal menstrual cycles using IMMULITE7 reproductive hormone assays, Clinical Chemistry 45 (S6):A92 (Abst. No. 322), 1999.

  46. O=Neil JS, Green AE, Swan KF, Gimpel TL, CASTRACANE VD, Henson MC. Estrogen regulation of leptin mRNA transcripts in cycling, pregnant, and fetectomized baboons, Biol Reprod 60 (Suppl.1):126 (No. 104), 1999.

  47. CASTRACANE VD, Henson MC, Gimpel TL, Tawwater BA. Pituitary, placental, and immunofunctional growth hormone (GH) in the pregnant baboon, Biol Reprod 60 (Suppl. 1):246 (No. 494), 1999.

  48. CASTRACANE VD, Tawwater BA, Gimpel TL. There is no effect of age or estrogen on the gender differences in morning growth hormone (GH) levels, Fert Steril 72 (Suppl.1): S190 (P-313), 1999.

  49. CASTRACANE VD, Tawwater BA, Gimpel TL. Pregnancy associated plasma protein:A (PAPP-A) and free beta hCG throughout pregnancy: A cross-sectional and longitudinal study of new methodologies, Fert Steril 72 (Suppl. 1):S190 (P-312), 1999.

  50. CASTRACANE VD, Santoro N. Tawwater BA, Adel G, Gimpel TL. Circadian leptin rhythm in the postmenopausal subject and the effect of estrogen replacement, Fert Steril 72 (Suppl. 1):S238 (P-456), 1999.

  51. CASTRACANE VD, Kraemer G, Brooks E, Kraemer RR, Gimpel TL. Relationship of BMI and the effect of abdominal vs. peripheral fat distribution on serum leptin levels in untreated postmenopausal women, Fert Steril 72 (Suppl.1):S237 (P-455), 1999.

  52. CASTRACANE VD. Pregnant with anticipation. Endocrinology of Pregnancy , Ed. Fuller W. Bazer, Totowa, Humana, 1998. Trends in Endocrinology and Metabolism 10(4):168, 1999.

  53. CASTRACANE VD. Reproduction encyclopedia rates a AWow!@ Encyclopedia of Reproduction, Ed. E. Knobil and JD Neill, San Diego, Academic Press, 1998. Trends in Endocrinology and Metabolism 10 (7):289, 1999.

  54. Mann DR, Akinbami MA, Gould KG, CASTRACANE VD. A longitudinal study of leptin during development in the male rhesus monkey: The effect of body composition and season on circulating leptin levels, Biology of Reproduction 62:285-291, 2000.

  55. Fanchin R, deZiegler D, Taieb J, Olivennes F, CASTRACANE VD, Frydman R. Hormonal dynamics after human chorionic gonadotropin administration in controlled ovarian hyperstimulation: Clues for suboptimal endometrial receptivity, Fertility and Sterility 73:275-279, 2000.

  56. Girgis R, Abrams SA, CASTRACANE VD, Gunn SK, Ellis KJ, Copeland KC. Ethnic differences in androgens, IGF-1, and body fat in healthy prepubertal girls, J Pediatr Endocrinol Metab 13:497-503, 2000.

  57. Butterstein GM, CASTRACANE VD. Effect of particle size on the prolonged action of subcutaneous danazol in male and female rats, Fertility and Sterility 74:356-358, 2000.

  58. Henson MC, CASTRACANE VD. Mini review: Leptin in pregnancy, Biol Reprod , 2000. (In press)

  59. Campbell MG, Tindell JL, Batt AM, Gimpel TL, CASTRACANE VD. Late rescue of the corpus luteum: Endocrine, sonographic and doppler studies, Journal of the Society for Gynecologic Investigation 7 , No. 1 (Program Suppl.):206A (Abst. 583), 2000.

  60. O=Neil JS, Green AE, Edwards DE, Swan KF, Gimpel TL, CASTRACANE VD, Henson MC. Effects of reduced estrogen availability on leptin and leptin receptor mRNA transcripts in fetectomized baboons, Journal of the Society for Gynecologic Investigation 7 , No. 1 (Program Suppl.):138A (Abst. 335), 2000.

  61. Sarver AD, Gimpel TL, Palmgren MS, Longo SA, CASTRACANE VD. A cross-sectional study of the somatotrophic family of hormones in diabetic pregnancy. Presented at the Endocrine Society 82 nd Annual Meeting, Toronto, Ontario, Canada, Program and Abstracts, p.555 (Abst. No. 2301), 2000.

  62. Sarver AD, Gimpel TL, CASTRACANE VD. Unexpected findings in the pattern of Inhibin A in diabetic pregnant patients. Presented at the Endocrine Society 82 nd Annual Meeting, Toronto, Ontario, Canada, Program and Abstracts, p.557 (Abst. No. 2306), 2000.

  63. Park SJ, Goldsmith LT, Reinert A, Skurnick JH, CASTRACANE VD, Weiss G. Perimenopausal women are deficient in an estrogen positive feedback on LH secretion mechanism. Presented at the Endocrine Society 82 nd Annual Meeting, Toronto, Ontario, Canada, Program and Abstracts, p.69 (Abst. No. 248), 2000.

  64. Butterstein G, Mahindra P, Williams J, CASTRACANE VD. Ether stress increases leptin levels in the rat. Presented at the Endocrine Society 82 nd Annual Meeting, Toronto, Ontario, Canada, Program and Abstracts, p.69 (Abst. No. 248), 2000.

  65. Provost T, Kennedy M, CASTRACANE VD, Meserve LA. Effect of polychlorinated biphenyl exposure on leptin and thyroid hormone levels: Influence of age of exposure. Presented at the Endocrine Society 82 nd Annual Meeting, Toronto, Ontario, Canada, Program and Abstracts, p.591 (Abst. No. 2443), 2000.

  66. Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, CASTRACANE VD. Variability of serum estrogen levels among postmenopausal women on transdermal estrogen replacement therapy (ERT). Presented at the Endocrine Society 82 nd Annual Meeting, Toronto, Ontario, Canada, Program and Abstracts, p.561 (Abst. No. 2323), 2000.

  67. Kraemer RR, Acevedo EO, Synovitz LB, Durand RJ, Johnson LG, Petrella E, Fineman MS, Gimpel TL, CASTRACANE VD. Glucoregulatory endocrine responses to exercise and the role of a pancreatic b-cell peptide, Amylin. Presented at the Endocrine Society 82 nd Annual Meeting, Toronto, Ontario, Canada, Program and Abstracts , p.428 (Abst. No. 1767), 2000.

  68. Johnson LG, Kraemer RR, Haltom R, Kraemer GR, Boler M, Durand R, CASTRACANE VD. Fat and carbohydrate utilization during exercise in postmenopausal women on and off hormone replacement therapy, Medicine and Science in Sports and Exercise 32 , No. 5 (Prog. Suppl.):S232 (Abst. 1109), 2000.

  69. CASTRACANE VD, Padilla SL, Gimpel TL, Dugan K. Is there a diagnostic role for serum Inhibin A in controlled ovarian hyperstimulation cycles? To be presented at the American Society for Reproductive Medicine, 2000.

  70. CASTRACANE VD. Endocrinology of preterm labor, Clin Obstet Gynecol , 2000. (In press)

  71. Mistry JS, Bodani U, Diamandis A, Khosravi MJ, CASTRACANE VD. A direct immunoassay for the quantitative determination of human inhibin-A. Clinical Chemistry 46(S6):A129, (Abst. No. 495), 2000.

  72. Butterstein GM, Mahindra PR, CASTRACANE VD. The effect of diet and adiposity on serum leptin levels in the female rat during early development, Biol Reprod 62 (Suppl.1):180 (No.188), 2000.

  73. O=Neil JS, Green AE, Edwards DE, Gimpel T, CASTRACANE VD, Henson MC. Effects of advancing gestation and fetectomy on leptin production in baboon pregnancy, Biol Reprod 62 (Suppl.1):257 (No. 382), 2000.

  74. Edwards DE, O=Neil JS, Green AE, Gimpel T, CASTRACANE VD, Henson MC. Regulation of soluble leptin receptor protein in baboon pregnancy: Effects of gestational age and fetectomy, Biol Reprod 62 (Suppl.1):198 (No. 232), 2000.

  75. Kauffman RP, Baker VM, DiMarino PA, CASTRACANE VD. Screening for insulin resistance utilizing fasting glucose/insulin levels in polycystic ovarian syndrome. To be presented at the American Society for Reproductive Medicine, 2000.

  76. Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, CASTRACANE VD. The effect of transdermal estrogen replacement therapy (ERT) in postmenopausal women on serum levels of androgens and sex hormone binding globulin (SHBG). To be presented at the American Society for Reproductive Medicine, 2000.

  77. Kraemer RR, Acevedo EO, Synovitz LB, Durand RJ, Johnson LG, Gimpel TL, CASTRACANE VD. Effects of moderate and intense exercise on leptin and testosterone levels in well-trained men. To be presented the American Society for Reproductive Medicine, 2000.

  78. Sarver AD, Gimpel TL, Jennings JC, CASTRACANE VD. Unexpected findings in the pattern of inhibin A in diabetic pregnant patients. To be presented at the Annual Meeting of the Central Association of Obstetricians and Gynecologists, 2000.

  79. CASTRACANE VD. Just right, too much...no! Too little! Hormone Replacement Therapy , Ed. A. Wayne Meikle, Totowa, Humana, 1999. Trends in Endocrinology and Metabolism 11(2):74, 2000.

  80. Kraemer RR, Synovitz LB, Gimpel TL, Kraemer GR, Johnson LG, CASTRACANE VD. Effect of estrogen on serum DHEA in younger and older women and the relationship of DHEA to adiposity and gender. (Submitted for publication), 2000.

  81. Butterstein GM, Doering C, CASTRACANE VD. Erythropoietin increase in the pregnant rat is mediated by increasing testosterone levels. (Submitted for publication), 2000.

  82. O=Neil JS, Green AE, Edwards DE, Swan KF, Gimpel TL, CASTRACANE VD, Henson MC. Regulation of leptin and leptin receptor in baboon pregnancy: Effects of advancing gestation and fetectomy. (Submitted for publication), 2000.

  83. CASTRACANE VD, Kauffman RP, Gimpel TL. Serum Inhibin A levels in polycystic ovarian disease (PCOD): Relationship to insulin resistance. Abstract to Endocrine Society Annual Meeting, Denver, CO, June 21, 2001.

  84. CHITTIVELU S. Lidocaine-induced myocardial injury, Hospital Practice , February, 2000.

  85. CHITTIVELU S. Lidocaine unlikely to cause methemoglobinemia, Hospital Practice , April, 2000.

  86. CHITTIVELU S. Case of the month, Am J Med 108:(7), May, 2000.

  87. Sherry Ludtke, CHUACHINGCO J. Intraventricular tobramycin in premature infants with pseudomonas ventriculitis, poster presented at the 10 th Annual Pediatric Pharmacy Advocacy Group Annual meeting, October 2001, St. Louis, MO. (Accepted for publication, Journal of Pediatric Pharmacology)

  88. Berk SL, DAVIS WR. PreTest Medicine, Self-Assessment and Review , 9 th Ed. New York, NY: McGraw-Hill, 2000.

  89. Kelleher S, DAVIS WR. Gout, bradycardia and hypercholesterolemia in a renal transplant patient, Southern Medical Journal , February, 2000.

  90. Kelleher SP, DAVIS WR. Paraskevopoulos N. Gout, bradycardia, and hypercholesterolemia after renal transplantation. South Med J, 2001; 94:732-734.

  91. JOAQUIN SANTOLAYA-FORGAS. Guest Editor=s Message. Panhandle Health , Spring 2003, Vol. 13, No. 2.

  92. JOAQUIN SANTOLAYA-FORGAS. Medical Genetics. Panhandle Health , Medical Genetics, Spring 2003, Vol. 13, No. 2.

  93. JOAQUIN SANTOLAYA-FORGAS, Meganne Walsh. Newborn metabolic screening: today and tomorrow, Panhandle Health , Spring 2003, Vol. 13, No. 2.

  94. Matheson JKB, Matheson VA, McCorquodale M, SANTOLAYA-FORGAS J. Prenatal diagnosis of double autosomal mosaicism (47, XX, +8/47, XX, +14): Phenotype and molecular cytogenetic analysis on different tissues. Fetal Diang Ther , 2003; 18:29-32.

  95. FREEMAN DE. Prenatal genetic diagnosis. Panhandle Health , Spring 2003, Vol. 13,

  96. No. 2.

  97. HALE TW. Medications and Mothers = Milk , Eighth Edition. Pharmasoft Medical Publishing, 1993-1999. This drug reference book is currently the major source for information in the lactation field and is sold in the USA, Canada, Australia, England, and Puerto Rico by a number of book retailers worldwide.

  98. HALE TW. Clinical Therapy in Breastfeeding Patients , First Edition, Pharmasoft Medical Publishing, 1999.

  99. HALE T, Kristensen J, Hackett L, Kohan R, Ilett K. Transfer of metformin into human milk, Diabetologia 45:1509-1514, 2002.

  100. HALE TW. Ilett K, Hartmann P. Effect of pseudoephedrine on human milk and prolactin production, Eur J Clin Pharmacol , 2002. (Accepted)

  101. HALE T, Ilett K, Hartmann P, Aljazaf K, Mitoulas L, Kristensen J, Hackett L. Pseudoephedrine effects on milk production in women and estimation of infant exposure via breastmilk, ISRHML 2002 , October 4, 2002, Mexico City.

  102. HALE T, Kristensen J, Hackett L, Kohan R, Ilett K. Transfer of metformin into human milk, ISRHML 2002 . October 4, 2002, Mexico City.

  103. HALE TW, Medications and Mothers = Milk 2002, Tenth Edition, 1000 pages. Pharmasoft Publishing 2002.

  104. HALE TW, Ilett KF, Drug Therapy and Breastfeeding: From Theory to Clinical Practice , First Edition ed. London: Parthenon Publishing, 2002.

  105. HALE TW, Berens P, Clinical Therapy in Breastfeeding Patients , Second edition, 2002.

  106. HAMPTON RM. Revisit an old friend, Trends in Endocrinology and Metabolism , Vol. 11, No. 3, April, 2000.

  107. Carl SH, HAMPTON RM. Normal saline pelvic and intrauterine irrigation in the high-risk cesarean section patient as a safe and cost effective method of infection prophylaxis. Society for Maternal-Fetal Medicine, January 31-February 5, 2000.

  108. Audet MC, Moreau M, Koltun WD, Waldbaum AS, Shangold G, Fisher AC, Creasy GW, (HAMPTON RM, Principal Investigator for Ortho EVRA/EVRA 004 Study Group). Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive, JAMA 285:2347-2354, 2001.

  109. HAMPTON RM. Guest Editorial, Panhandle Health , Winter 2002.

  110. HAMPTON RM. Assessing faculty professionalism: Putting the shoe on the other foot!@ Poster presentation at the 2002 CREOG/APGO Annual Meeting, Dallas, TX, as completion of the APGO/Solvay Educational Scholars Program.

  111. JENNINGS JC. Multiple thoughts about multiple births, Texas Medicine 95 (4):29, April, 1999.

  112. JENNINGS JC. Clinical spectrums of osteoporosis, Long Term Care Update , April, 1999.

  113. JENNINGS JC. Held B, Tabb TN. Practical Reviews in Obstetrics and Gynecology , 12 volumes, Jan-Dec, 1999.

  114. JENNINGS JC. Read it when you need it, Reproductive Endocrinology and Physiology, Pathophysiology, and Clinical Management , 4 th Edition. Edited by Samuel S.C.Yen, Robert B. Jaffee, Robert L. Barbieri. Philadelphia, Saunders, (xvi + 839 pages), ISBN 0-7216-6897-6, 1999.

  115. JENNINGS JC. Held B, Tabb TN. Practical Reviews in Obstetrics and Gynecology , 12 volumes, Jan-Dec, 2000.

  116. JENNINGS JC. Ethics of authorship, Texas Medicine 96 (2):42-46, February, 2000.

  117. JENNINGS JC. Held B, Tabb TN, Practical Reviews in Obstetrics and Gynecology , 12 volumes, Jan-Dec 2001.

  118. JENNINGS JC. The Importance of infant mortality statistics, Texas Medicine , July, 2001, 97 (7):64. Understanding and treating the menopause, Panhandle Health , January, 2001.

  119. JENNINGS JC, Held B, Tabb TN. Practical Reviews in Obstetrics and Gynecology, Vol. 19-26, 2001.

  120. JENNINGS JC, Understanding and Treating the Menopause, Panhandle Health , January 2001.

  121. Kauffman RP, Overton TH, Shiflet M, JENNINGS JC. Osteoporosis in children and adolescent girls: Case report of idiopathic juvenile osteoporosis and review of the literature. Obstetrical and Gynecologic Survey 56 (8):492-504, August, 2001.

  122. Gilger MA, Tolia V, JOHNSON A, et al. The use of an oral fluid immunologlobulin G Elisa for the detection of Helicobacter pylori infection in children, Helicobacter 2002 ; 7(2).

  123. Buchowski M, Semenya J, JOHNSON AO. Dietary calcium intake in lactose maldigesting intolerant African American adolescent women. J Am Coll Nutr 2002; 21(1):47-52.

  124. KAUFFMAN RP. Hormone resistance syndromes, Trends in Endocrinology and Metabolism, Vol. 10, No. 10:427-4288, 1999.

  125. KAUFFMAN RP. Progestins and antiprogestins in clinical practice: Now available in assorted flavors, Trends in Endocrinology and Metabolism , Vol. 11, No. 8:342-343, 2000.

  126. KAUFFMAN RP. The obstetrician and gynecologist: Making a difference in the new millennium, Panhandle Medicine 11 (1):35-36, Winter 2000.

  127. KAUFFMAN RP, Overton TH, Shiflett M, Jennings JC. Osteoporosis in pediatric and adolescent girls: A case of idiopathic juvenile osteoporosis. Case report and review of the literature, Obstetrical and Gynecological Survey 56 (8):492-504, 2001.

  128. KAUFFMAN RP. The emerging role of the gynecologic oncologist in the community, Panhandle Health 11 (3):13-15, 2001.

  129. KAUFFMAN RP. Reproductive technology and reproductive ethics: Does one hand know what the other is doing? Panhandle Health 12 (1):22-25, 2001.

  130. KAUFFMAN RP, Baker VM, DiMarino PA, Castracane DV. PCOS in Hispanic and Caucasian Women: Tests of insulin resistance. Abstract to Central Association of Obstetricians and Gynecologists Scientific Meeting, San Francisco, CA, October 12, 2001.

  131. KAUFFMAN RP, Castracane VD. Screening for insulin resistance in polycystic ovarian disease: Is there a role for GH, SHBG, IGF-1, and IGFBP-1? Abstract to American Society of Reproductive Medicine Annual meeting, Orlando, FL, October 23, 2001.

  132. KAUFFMAN RP, Overton TH, Shifflet M, Jennings JC. An adolescent female with idiopathic juvenile osteoporosis presenting to a university gynecologic service. Abstract to American Society of Reproductive Medicine Annual meeting, Orlando, FL, October 23, 2001.

  133. KAUFFMAN, RP, Baker VM, Gimpel T, DiMarino P, Castracane VD. Polycystic ovarian syndrome in Caucasian and Mexican American women: Screening for insulin resistance in large populations. Am J Obstet Gynecol 2002; 187:1362-9.

  134. KAUFFMAN RP. Editor=s message: Who=s afraid of HRT? Panhandle Health , Spring 2003, Vol. 13, No. 2.

  135. KELLEHER S, Davis WR. Gout, bradycardia and hypercholesterolemia in a renal transplant patient, Southern Medical Journal , February, 2000.

  136. Chiriva-Internati M, LIM SH, et al. Expression of surface CD 40 and immunocytochemical actin-bundle protein Fascin in dendritic cells from multiple myeloma treated with retinoids during their differentiation in vitro , in vitro Cell Dev Biol Anim 2001; 37:641-643.

  137. Chiriva-Internati M, Wang Z, LIM SH, et al. Sperm protein 17 (SP 17) in multiple myeloma: Opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-host effect without increasing graft-verus-host risk. European Immunol 2001; 31:2277-2283.

  138. LIM SH, Wang Z, Chiriva-Internati M, et al. Sperm protein 17 is a novel cancer-testis antigen in multiple myeloma. Blood 2001; 97:1508-1510.

  139. LIM SH, et al. Distinct T cell clonal expansion in the vicinity of tumor cells in plasmacytoma. Cancer 2001; 91:900-908.

  140. LIM SH, Chiriva-Internati M, Wang Z. MAGE-C1 (CT7) gene expression in multiple myeloma: Relationship to sperm protein 17. European J Haematol 2001; 67:332-334.

  141. LIM SH, Periman P, Klug P, Weidanz J, Whitton V, Chiriva-Internati M, Wang Z, Klug P. Defining tumor antigens: RNA, protein or cytotoxicity? Trends in Immunology , 23:236-237, 2002.

  142. Grizzi F, LIM SH, Chiriva-Internati M, FrancesChini B, Wang Z, Lawrence D, Dioguardi N. Sperm protein 17 is not expressed on normal leukocytes. Blood 2002; 99:3479-3480.

  143. Chiriva-Internati M, Wang Z, Salati E, Timmins P, LIM SH. Sperm protein 17 (Sp17) as a target for immunotherapy of ovarian cancer, Cancer 2002; 94:2447-2453.

  144. Chiriva-Internati M, Wang Z, Salati E, Wroblewski D, LIM SH. Successful generation of sperm protein 17 (Sp17)-specific cytotoxic T lymphocytes from normal donors: Implication for tumor-specific adoptive immunotherapy following allogeneic stem cell transplantation for Sp17-positive multiple myeloma, Scand J Immunol , 2002;56:429-433.

  145. Chiriva-Internati M, Liu Y, Salati E, Zhou W, Wang Z, Grizzi F, Roman JJ, LIM SH, and Hermonat PL. Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells, Eur J Immunol, 2002;32:30-38.

  146. LIM SH. Hematopoietic stem cell transplantation: Ethical issues, Panhandle Health , 2002; 13:25-26.

  147. Chiriva-Internati M, Want Z, Salati E, Bumm K, Barlogie B, LIM SH. Sperm protein 17 (Sp17) is a suitable target for immunotherapy of multiple myeloma, Blood, 2002; 100:961-965.

  148. Rogers SA, Bowen DJ, Ling M, Thomson P, Wang Z, LIM SH. Identification and characterization of a novel gene encoding a SEREX antigen in chronic myeloid leukaemia, British Journal of Haematology, 2002; 119:112-114.

  149. LIM SH, Zhang Y, Chiriva-Internati M, Esler WV, Townsend M, Smith P, Burris C, Klug P. AUltralite@ allogeneic HSCT: Towards a chemotherapy-free outpatient transplant regimen, Proceedings of the Annual Scientific Meeting of the American Society of Hematology, Philadelphia, USA, 12/4/2002.

  150. Wang Z, Zhang Y, Liu H, Salati E, Chiriva-Internati M, LIM SH. SPAN-Xb: A normal testicular antigen aberrantly expressed and induces immune responses in hematologic malignancies, Proceedings of the Annual Scientific Meeting of the American Society of Hematology, Philadelphia, USA, 12/4/2002.

  151. Zhang Y, Wang Z, Liu H, LIM SH. Semenogelin 1 is aberrantly expressed with other CT antigens and induces B-cell responses in chronic myeloid leukemia, Proceedings of the Annual Scientific Meeting of the American Society of Hematology, Philadelphia, USA, 12/4/02.

  152. LIM SH, Chiriva-Internati M, Wang Z, Salati E. Sperm protein 17 (Sp17) as a tumor vaccine in multiple myeloma, Proceedings of the Annual Scientific Meeting of the American Society of Hematology, Philadelphia, USA, 12/4/02.

  153. Chiriva-Internati M, Wang Z, Salati E, LIM SH. Mapping the CTL epitope of a novel CT antigen, sperm protein 17 (Sp17), restricted by HLA-A1, Proceedings of the Annual Scientific Meeting of the American Society of Hematology, Philadelphia, USA, 12/4/02.

  154. LUCKSTEAD EF. Cardiovascular evaluation of the young athlete, Am Stars 9 (3):441-455, Kelly CK, Pestian JP, Andersen CL, Strope G, 1998.

  155. Greydanus DE, Patel DR, LUCKSTEAD EF. Adolescent state of art reviews, Office Orthopedics and Sports Medicine , Hanley and Belfus, 9:3, 1998.

  156. Pestian JP, Owen WC, Hughes S, Wneger E, Vasser E, LUCKSTEAD EF. Utilization of a clinical pathway to facilitate management of sickle cell disease related vaso-occlusive events in children, Submitted Journal of Hematology and Oncology , March, 1999.

  157. LUCKSTEAD EF. The impact of pediatric inpatient asthma clinical pathway on quality and cost, submitted to Ann of Allergy and Immunology , March, 1999.

  158. Mares SC, LUCKSTEAD EF. Hip, pelvic and thigh injuries, Asian Journal of Pediatric Practice. (In press for February 2000)

  159. Metzl J, LUCKSTEAD EF. Shoulder pain and injuries in the athlete. (In press for February 2000)

  160. LUCKSTEAD EF, Chapter 10: Cardiac risk factors and participation guidelines for youth sports, Pediatr Clin N Am , 49:681-707, August 2002.

  161. LUCKSTEAD EF, Satran AL, Patel DR, Chapter 14: Sport injury profiles, training and rehabilitation issues in American sports, Pediatr Clin N Am , 49:753-767, August 2002.

  162. Patel DR, Stier B, LUCKSTEAD EF, Chapter 15: Sport injury profiles, training and rehabilitation issues in International sports, Pediatr Clin N Am , 49:768, August 2002.

  163. LUCKSTEAD EF, Patel DR, Chapter 5: Catastrophic pediatric sports injuries, Pediatr Clin N Am , 49:581-591, June 2002.

  164. LUCKSTEAD EF, Pediatric Sports Medicine , Two volume issues, (Guest Editor: Preface 49:XIII-XV/Epilogue, 49:857-859) June/August 2002.

  165. LUCKSTEAD EF, Pediatric Clinics of North America, WB Saunders (Editor), Double Issue, Pediatric Sports Medicine , June/August 2002.

  166. LUCKSTEAD EF, Contributing Editor AAP Grand Rounds: Sports Medicine (1998-present)

  167. MORGAN JL. Diagnosing a broken heart, TEM 11:76-77, 2000.

  168. MORGAN JL. The evaluation and treatment of urinary incontinence, Panhandle Health 2000.

  169. MYLES TD. The Jarisch-Herxheimer reaction and fetal monitoring changes in pregnant women treated for syphilis, Obstetrics and Gynecology 93:631-632, 1999.

  170. MYLES TD. United States medical licensure examination Step1 scores and obstetrics-gynecology clerkship final examination, Obstetrics and Gynecology 94:1049-1051,1999.

  171. Romero R, Sibai BM, Sanchez-Ramos L, Valenzuela GJ, Veille JC, Tabor B, Perry KG, Varner M, Goodwin T, Lane R, Smith J, Shangold G, Creasy GW, MYLES TD. Randomized, double-blind, placebo-controlled trial of an oxytocin receptor antagonist (atosiban) in the treatment of preterm labor, Am J Obstet Gynecol 1173-83, 2000.

  172. Valenzuela GJ, Sanchez-Ramos L, Romero R, Silver HM, Koulton WD, Millar L, Hobbins J, Rayburn W, Shangold G, Want J, Smith J, Creasy GW, MYLES TD. A randomized double-blind placebo-controlled trial of an oxytocin receptor antagonist (atosiban) for the maintenance of uterine quiescence of patients with preterm labor, Am J Obstet Gynecol 182:1184-1190, 2000.

  173. MYLES TD, Morgan JL, Santolaya J. Normal values and clinical application of the deepest vertical amniotic fluid pocket at term, Journal of Reproductive Medicine . (In press)

  174. MYLES TD, Santolaya J. R Levi-D Ancona, Nelson L. Influences of embryonic surgance/heart rate on amniotic fluid accumulation before the 11 th week gestation. Abstract to American Institute of Ultrasound Medicine 45 th Annual meeting, 2001.

  175. MYLES TD. A comparison between obstetrics and gynecology final examination scores at university and community hospitals, J Reprod Med 46:371-375, 2001.

  176. MYLES TD, Santolaya J. Intrapartum ultrasonographic evaluation of the amniotic fluid for prediction of cesarean section, Abstract to the American Institute of Ultrasound Medicine 45 th Annual meeting, 2001.

  177. Appel C, MYLES TD. Hypokalemic paralysis in pregnancy from excessive caffeine consumption, Obstet Gynecol 97:805-807, 2001.

  178. MYLES TD, Galvez-Myles R. Relationship between obstetrics and gynecology clerkship subjective grade and examination score at community and university sites, J Reprod Med 46:729-734, 2001.

  179. MYLES TD, Nguyen TM. Relationship between normal amniotic fluid index and birthweight in term patients presenting for labor, J Reprod Med 46:685-690, 2001.

  180. Seo TS, Matheson J, Criswell TL, Santolaya J, MYLES TD, Castracane VD. Amniotic fluid alpha feto protein (AFAFP) during the second trimester of pregnancy: Are there ethnic variations? J Perinat Med (Suppl. 1 Part 1) 29, 2001.

  181. Santolaya J, Gimpel T, MYLES TD. Prenatal genetic counseling in inner-city hospitals in USA: Serving patients rather than policy-makers, Perinat , 2001.

  182. MYLES TD. Vaginal birth after cesarean delivery in the twin gestation, J Maternal-Fetal Med 10:171-174, 2001.

  183. MYLES TD. Relationship between deepest vertical amniotic fluid pocket and birthweight in term patients with intact membranes, Abstract in the Am J Obstet Gynecol , 2001; 184-498.

  184. MYLES TD, Henderson RC. United States Medical Licensing Examination Step I and Step II scores relationship for obstetrics and gynecology and examination score, Poster presentation at the 2001 Annual CREOG/APGO meeting.

  185. MYLES TD, Henderson RC. Obstetrics and gynecology clerkship clinical evaluation correlate with both the United States Medical Licensing Step II examination performances and the clerkship final examination, Poster presentation at the 2001 Annual CREOG/APGO meeting.

  186. MYLES TD. Third year obstetrics and gynecology final examination scores are lowered by a shorter clerkship length, Poster presentation at the 2001 CREOG/APGO meeting.

  187. George M, NAQVI M, Haase M. Methylene blue induced hyperbilirubinemia and photo-toxicity in a neonate, Accepted for publication Clinical Pediatrics , 2000.

  188. NAQVI M. The Vermont Oxford trials network: Morbidity and mortality among very-low birth weight neonates with intrauterine growth restriction, Am J Obstet Gynecol 182 (1):198-206, 2000.

  189. Rush S, Rush R, NAQVI M, Rush JA. Retinopathy of prematurity, incidence and associated factors in infants with birthweight #1500 grams or gestational age #32 weeks. American Academy of Pediatrics 2001 National Conference and Exhibition, October 2001.

  190. Santaloya-Jorgas J, Valentine S, NAQVI M. Spontaneous inutero resolution of second trimester CNS ventriculomegaly and hydrops intercranial, Congress on Ultrasound in Obstetrics and Gynecology 2002.

  191. NIXON-LEWIS, Management of abnormal PAP smear, TAFP symposium, Fall 2002.

  192. OLTERMANN M. Immune formulas in the ICU, American Dietetic Association, Philadelphia, PA, October 20, 2002.

  193. OLTERMANN M. Permissive underfeeding in the ICU, American Dietetic Association, Philadelphia, PA, October 20, 2002.

  194. OVERTON TH. Osteoporosis, Panhandle Health , 11(2):16, 2001.

  195. Kauffman RP, OVERTON TH, Shiflett M, Jennings JC. Osteoporosis in pediatric and adolescent girls: A case of idiopathic juvenile osteoporosis, Case report and review of the literature, Obstetrical and Gynecological Survey 56 (8):492-504, 2001.

  196. OVERTON TH. Osteoporosis overview for academic and clinician, The Osteoporosis Primer, Editor Janet E. Henderson and David Glotzman, Cambridge University press, 2000, Trends in Endocrinology and Metabolism 13 (1):45, 2001.

  197. OVERTON TH. Osteoporosis overview for academic and clinician. (Book Review), The Osteoporosis Primer, Ed Henderson JE, Glotzman D, Cambridge University Press, 2000. Trends in Endocrinology and Metabolism 13(1):45, 2002.

  198. PHILLIPS CA, McWherter R, Klug P, Rewers-Felkins K, Robinson W, Quinlan I, Byrd BF, Wright SE: Trafficking as a consideration in adoptive immunotherapy: How does the route of administration affect the delivery of cytotoxic T lymphocytes to tumor? J Immunotherapy 25(6):S34, November/December, 2002.

  199. Furlong C, Yokum JS, PHILLIPS CA, RJ Pryputniewicz: Optoelectronic holography shape characterization of microspheres for biomedical applications, MEMS/NEMS: Mechanics and Measurements, 2002.

  200. PHILLIPS CA, Immunotherapy of mucin producing tumors, BWTX-Pantex, Applied Technology Seminar series, March 20, 2002.

  201. PHILLIPS CA, McWherter R, Immunotherapy of breast cancer, Career Showcase, Amarillo Area Center for Advanced Learning, February 22, 2002.

  202. REVELL T. The changing picture of Medicare: Telemedicine and correctional health care, Journal of Correctional Health Care . (Publishing pending)

  203. Kahan Z, Arencibia J, Csernus V, Groot K, Kineman R, ROBINSON W, Schally A. Expression of growth hormone releasing-hormone (GHRH) mRNA and the presence of biologically active GHRH in human breast, endometrial and ovarian cancers, J Clinical Endocrin and Metabo , Volume 84, Number 2, p.582-589, February, 1999.

  204. ROBINSON W. Mamdoohin N, Adams J, Kline R. Technical aspects of intra peritoneal administration of a gene-modified ovarian cancer vaccine, J Gynecol Tech 5:79-82, 1999.

  205. ROBINSON W. Hamilton CA, Micheals SH, Kissinger P. The effects of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in human immunodeficiency virus-infected women, Am J Obstet Gynecol . (In press)

  206. ROBINSON W. Gynecologic surgery in the role of surgery in AIDS: Outcomes-based approach, Ed., D.Flumm, M. Wallack. Lippincott, Williams and Wilkins, p.139-204, 1999.

  207. ROBINSON W. Diagnosis and management of cervical neoplasia cancer treatment and research: HIV-associated malignancies, Ed.J.Sparano, Kluwer Academic publishers. (In press)

  208. ROBINSON W. Diagnosis and management of cervical neoplasia in seminars in oncology, Ed., A. Levine, W.B. Saunders, 27 (4):463-469, 2000.

  209. ROBINSON WR. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for Stage IIB-IVA carcinoma of the cervix: A Southwest Oncology Group Study, Abstract presented to Society of Gynecologic Oncologist Annual meeting, Nashville, TN, March 2001.

  210. ROHLAND BM. Telepsychiatry in the Heartland: If we build it, will they come? Community Mental Health Journal , 37(5):449-459, 2001.

  211. ROHLAND BM. Self-report of improvement following hospitalization for ECT: Relationship to functional status and service use administration and policy, Mental Health , 28(3):193-203, 2001.

  212. ROHLAND B. Psychiatric emergencies, Panhandle Health , 12(3):37-38, 2002.

  213. ROHLAND B. Training psychiatrists for West Texas, Panhandle Health , 12(4):27-28, 2002.

  214. Kruse GR, ROHLAND BM, Wu X. Factors associated with missed first appointments to a psychiatric clinic, Psychiatric Services , 53(9):1173-1176, 2002.

  215. Kruse GR, ROHLAND BM. Factors associated with attendance at a first appointment after discharge from a psychiatric hospital, Psychiatric Services , 53(4):473-476, 2002.

  216. Rohrer JE, Borders TF, ROHLAND BM, High-use of medical care among elderly persons with heart disease, Texas J Rural Health , 20(1):34-43, 2002.

  217. ROHLAND B. World Mental Health Casebook: Social and mental health programs in low-income countries, Psychiatric Services , 54(1):118-119, 2003.

  218. ROHLAND B. Provision of behavioral health services by primary care providers in rural areas: Opportunity, responsibility, and politics, Journal of Rural Health ,19(1):4, 2003.

  219. Tasman A, Kay J, & Lieberman JA: Psychiatry , Second Edition 2003, John Wiley & Sons, Ltd., England, 2 Volumes (2344 pages), Chapter 114: Rural Psychiatry, BARBARA M. ROHLAND (pp. 2322-2326).

  220. SANTOLAYA J. Interventional ultrasound, Obstetrics and Gynecology , Lemery D (Eds), Blackwell, 1998.

  221. Lin CC, SANTOLAYA J. Current concepts of fetal growth restriction: Part II. Diagnosis and management, Obstet Gynecol 93:140-146, 1999.

  222. SANTOLAYA J, Meyer W, Gauthier D, Vengalil S, Duval J, Gottmann D, DeChristopher J. Use of recombinant human erythropoietin (EPO-ALFA) in a mother with anti-Jsb antibodies, J Mat Fetal Med 8:141-145, 1999.

  223. Vengalil S, Meyer W, SANTOLAYA J. Hydrops fetalis, Fetal and Neonatal Ultrasonography , Haller J, Jaffe R (Eds) Parthenon , 1999.

  224. SANTOLAYA J. Fetal medicine: A new clinical specialty, Panhandle Health 12; 1:26-29, 2001.

  225. SANTOLAYA J. How do we counsel patients carrying a fetus with pleural effusions? Ultrasound in Obstet & Gencol, 18:305-308, 2001.

  226. SANTOLAYA J. Prenatal genetic counseling in inner-city hospitals in USA: Serving patients rather than policy-makers, 5 th World Congress of Perinatal Medicine, J Perinatal Med 29:Suppl, Part 1:53, 2001.

  227. Seo T, Matheson J, Criswell T, Myles TD, Castracane VD, SANTOLAYA J. Amniotic fluid alpha feto protein (AFAFP) during the second trimester of pregnancy: Are there ethnic variations? 5 th World Congress of Perinatal Medicine, J Perinat Med , 29: Suppl., Part 1:83, 2001.

  228. Myles TD, SANTOLAYA J. Normal ultrasonic evaluation of the amniotic fluid in low risk patients at term: Reassuring sign, J of Reproductive Med. (Publication pending)

  229. SANTOLAYA J, Leon-Luis JD, D=Ancona RL, Morgan JL, Kauffman RP. Evolution of the amniotic SAC and extracelomic space as seen by early ultrasound examination, IFMSS. (In press)

  230. SANTOLAYA J, Ramakrishna M, Gimpel TL, Criswell T, Castracane VD. Fetal glucoregulatory response following graded increases in maternal glucose infusion in the non-human primate model.

  231. Ramkrishna M, SANTOLAYA J. Intermittent and continuous morphine administration in the control of post-operative uterine activity in a tethered pregnant baboon, Poster and abstract to the Society for Gynecologic Investigation, 2001.

  232. SANTOLAYA J, Shen Z, Hewitt T, McCorquodale M. Growth of extracoelemic cells obtained at 40 days gestation in the baboon model: A comparison of four methods, Poster and abstract to the International Congress of Human Genetics, 2001.

  233. SANTOLAYA J, Hewit T, Shen Z, McCorquodale M. Preliminary report on technical issues concerning the in-vitro growth of extracoelomic cells for chromosomal studies using the pregnant baboon mode, Poster and abstract to the International Congress of Human Genetics, 2001.

  234. Mancera K, Field F, Cohen L, Powell E, Matheson J, SANTOLAYA J. Efficacy of a prenatal screening-diagnosis program in Hispanic patients attending a USA urban state university medical center, Poster and abstract to the International Congress of Human Genetics, 2001.

  235. SCHNEIDER SC, Tan GB, Egerton DR, Hale TH. A comparison of the neuropsychological effects of methylphenidate and natural substances versus placebo on children with attention-deficit hyperactivity disorder, submitted to Pediatrics , April, 1999.

  236. SCHNEIDER SC, Tan GB, Egerton DR, Hale TH. A comparison of the neuropsychological effects of methylphenidate and natural substances versus placebo on children with attention-deficit hyperactivity disorder, Experimental Biology 1999. Abstract presented April 21, 1999. Washington, D.C.

  237. Smith JK, SIDDIQUI AA, Krishnaswamy GA, Dykes R, Berk SL, Magee M, Joyner W, Cummins J. Oral interferon-alpha stimulates ISG-15 transcription and production by human buccal epithelial cells, J Interferon Cytokine Res 19:923-928, 1999.

  238. Smith JK, SIDDIQUI AA, Modica L, Dykes R, Simmons C, Schmidt J, Krishnaswamy G, Berk SL. Interferon alpha upregulates gene expression of aquaporin-5 in cultured human parotid glands, J Interferon Cytokine Res 19:929-935, 1999.

  239. SIDDIQUI AA, Guiterrez C, Berk SL. Diagnosis of strongyloides stercoralis by acid-fast staining, J.Helminthol 73:187-188, 1999.

  240. Robinson J, Ahmed Z, SIDDIQUI AA, Roy T, Berk SL, Smith JK, Krishnaswamy G. A patient with persistent wheezing, sinusitis, elevated IgE and eosinophilia, Annuals of Allergy Asthma & Immunol 82:144-149, 1999.

  241. SIDDIQUI AA, Stanley CS, Berk SL. Cloning and expression of isocitrate lyase from human round worm, strongyloides stercoralis , Parasite 7:233-236, 2000.

  242. SIDDIQUI AA, Stanley CS, Berk SL. A cDNA encoding the highly immunodominant antigen of strongyloides stercoralis: g-subunit of isocitrate dehydrogenase (NAD + ), Parasitol Res 86:270-278, 2000.

  243. Chakkalath HR, SIDDIQUI AA, Shankar AH, Dobson DE, Beverley SM, Titus RG. Priming of a b-galactosidase (b-GAL)-specific Type 1 response in Balb/c mice infected with b-GAL-transfected Leishmania major, Infection & Immunity 68:809-814, 2000.

  244. SIDDIQUI AA, Stanley CS, Skelly PJ, Berk SL. A cDNA encoding a nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily from the human parasitic nematode, strongyloides stercoralis , Parasitol Res 86:24-29, Erratum appeared in: Parasitol Res 86:613, 2000.

  245. Myers JW, Simmons CI, Berk SL, SIDDIQUI AA. A case of strongyloides stercoralis in a young pregnant woman: Successful treatment with ivermectin and detection of circulating antigens, Rivista di Parassitologia XVII(LXI): 203-208, 2000.

  246. SIDDIQUI AA, Berk SL, Genta GM. Strongyloidiasis. In: Infections of Gastrointestinal Tract , 2 nd Edition. Ed: Blaser, Smith, Ravdin, Greenberg & Guerrant, Lippincott, Williams & Wilkins, Philadelphia, Chapter 69, 2001.

  247. SIDDIQUI AA, Berk SL. Diagnosis of strongyloides stercoralis infection, Clin Infect Dis 33:1040-1047, 2001.

  248. SIDDIQUI AA, Stanley CS, Berk SL. Isolation of a cDNA encoding an IgG immunoreactive antigen (zinc finger protein) of s trongyloides stercoralis , Parasite 8:163-167, 2001.

  249. SIDDIQUI AA, Phillips T, Charest H, Podesta RB, Quinlin ML, Pinkston JR, Lloyd JD, Paz M, Villalovos RM, Pompa J, 2002. Induction of protective immunity against Schistosoma mansoni via DNA priming with the large subunit of calpain (Sm-p80): Adjuvant effects of granulocyte macrophage colony stimulating factor and interleukin-4, Vaccine. (Accepted)

  250. SIDDIQUI AA, Phillips T, Charest H, Podesta RB, Quinlin ML, Pinkston JR, Lloyd JD, Pompa J, Villalovos RM, Paz M, 2002. Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation, Vaccine. (Accepted)

  251. Shah RB, SIDDIQUI AA, Shah GV, Khan MA. A validated HPLC assay for the simultaneous analysis of salmon calcitonin and duck ovomucoid, Pharmazie , 2002. (Accepted)

  252. SIDDIQUI AA, Genta GM, Berk SL. Strongyloidiasis, Chapter 70, In: Infections of Gastrointestinal Tract, 2 nd Edition. Editors: Blaser, Smith, Ravdin, Greenberg and Guerrant, Lippincott, Williams & Wilkins, Philadelphia, p.1113-1126, 2002.

  253. SIDDIQUI AA, Berk SL. Strongyloidiasis, Current treatment options, Infect Dis. (Accepted)

  254. Palamakula A, SIDDIQUI AA, Khan M. Evaluation of permeability characteristics of coenzyme Q10 using caco-2 cell monolayers. American Association of Pharmaceutical Scientist's Annual Meeting and Exposition, Salt Lake City, Utah (October 26-30, 2003).

  255. Shah RB, SIDDIQUI AA, Khan MA. A validated HPLC assay for simultaneous analysis of salmon calcitonin and duck ovomucoid. American Association of Pharmaceutical Scientist's Annual Meeting and Exposition. Salt Lake City, Utah (October 26-30, 2003).

  256. STENHOUSE A, Bioterrorism: Chemical and biological warfare, 17 th Annual Critical Care Conference, Corpus Christi, TX, August 15, 2002.

  257. Advani S, Pai S, Venzon D, Adde M, Kurkure PK, Nair CN, Sirohi B, Banavali SD, Hawaldar R, Kolhatkar BB, VATS TS, Magrath I. Acute lymphoblastic leukemia in India: An analysis of prognostic factors using a single treatment regimen, Annals of Oncology 10:167-176, 1999.

  258. VATS TS. Urogenital tumors, Progress in Pediatric Urology , Vol 2, p.118-138, 1999.

  259. VATS TS, Morad A, Kady T. Urological tumors of infancy and childhood, Indian Journal of Pediatrics . (In press)

  260. VATS TS, Morad A. Hodgkin=s and non-Hodgkin=s lymphoma in children, Indian Journal of Pediatric Hem/Onc . (In press)

  261. VATS TS. Malignancies in childhood, Essential Pediatrics, 5 th Edition, O.P.Ghai Editor Interprise. (In press)

  262. VATS T. Pediatric non-Hodgkin=s lymphomas in children: Diagnosis and current management, Indian Pediatrics , Vol 38:583-588, June 2001.

  263. VATS TS. Improving survival in childhood cancer, Panhandle Health , Vol 11(3):35-7, Summer 2001.

  264. VATS TS. Luce J, Adolescents and tobacco, Panhandle Health , Vol 12(2):34-5, Spring 2002.

  265. WINSTON T. Acute prostatitis, TAFP symposium, Fall 2002.

  266. WRIGHT CV. Medical professional ethics and business ethics: A clash in values? Presentation at Panhandle Chapter Texas Academy of Family Physicians, 2000.

  267. Kingston BJ, WRIGHT CV. Influenza in long care facilities, Infections in the Nursing Home, Editors, Berk, Vergese, submitted January 2001.

  268. Kingston BJ, WRIGHT CV. Influenza in the nursing home, American Family Physician, 65(1):75-78, 2002.

  269. WRIGHT CV. Presentation of management degree for the academic physician, Family Medicine Leadership Conference, Austin, TX, 2002.

  270. Dolby N, Dombrowski KE, WRIGHT SE. Design and expression of a synthetic mucin gene fragment in escherichia coli, Protein Expr Purif 15:146-154, 1999.

  271. WRIGHT SE, Sicola VR, Martinez H, Thompson E, Pratt D. Adjuvant chemotherapy and radiation therapy for elimination of residual microscopic non-small cell lung cancer, Int J Oncol 14:347-351, 1999.

  272. Lie H, WRIGHT SE. Enhanced HIV-1 envelope-tumor protection by a recombinant vaccinia virus expressing anchored HIV-1gp120 lacking gp41, Int J Mol Me 3:397-400, 1999.

  273. WRIGHT SE, Kilinski L, Talib S, Lowe KE, Burnside JS, Wu JY, Dolby N, Dombrowksi KE, Lebkowski JS, Phillip R. Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a Glycosylation site, J Immunother 23 (1):2-10, 2000.

  274. WRIGHT SE, Rewers-Felkins KA, Quinlin IS, Eldridge PW, Zorsky PE, Klug PP, Phillips CA, Philip R. Adoptive immunotherapy of mucin 1 expressing adenocarcinomas with mucin 1 stimulated human peripheral blood mononuclear cells, Int J Mol Med, 9:401-404, 2002.

  275. YOUNG R. Presentation entitled AAnticipatory Guidance in Family Practice: A Seminar Curriculum for Residents,@ Family Practice Faculty Development Center of Texas, Waco, TX, January 2003.

  276. YOUNG R. Poster presentation entitled AHow do Family Physicians provide anticipatory guidance during well-child visits,@ Family Practice Faculty Development Center of Texas, Waco, TX, April 2003.
©